Header cover image
  • Investing Ideas
  • Emirati Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Emirati Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Gulf Pharmaceutical Industries P.S.C

Market Cap: د.إ1.2b

Manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally.

JULPHAR

د.إ1.00

7D

-1.1%

1Y

-24.3%